Your browser doesn't support javascript.
loading
Role for µ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127.
Moriya, Yuki; Kasahara, Yoshiyuki; Shimada, Masafumi; Sakakibara, Yasufumi; Fujii, Hideaki; Nagase, Hiroshi; Ide, Soichiro; Ikeda, Kazutaka; Hall, F Scott; Uhl, George R; Sora, Ichiro.
Afiliación
  • Moriya Y; Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Kasahara Y; Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Maternal and Fetal Therapeutics, Tohoku University Graduate, School of Medicine, Sendai, Japan; Department of Maternal and Child Healthcare Medical Science, Tohoku, University Graduate Sc
  • Shimada M; Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sakakibara Y; Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurogenetics, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Fujii H; Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, Japan.
  • Nagase H; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan.
  • Ide S; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Ikeda K; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Hall FS; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USA.
  • Uhl GR; Departments of Neurology and Pharmacology, University of Maryland School of Medicine, and VA Maryland Healthcare System, Baltimore, MD, USA.
  • Sora I; Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: sora@med.kobe-u.ac.jp.
J Pharmacol Sci ; 151(3): 135-141, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36828615
Previous pharmacological data have shown the possible existence of functional interactions between µ- (MOP), κ- (KOP), and δ-opioid receptors (DOP) in pain and mood disorders. We previously reported that MOP knockout (KO) mice exhibit a lower stress response compared with wildtype (WT) mice. Moreover, DOP agonists have been shown to exert antidepressant-like effects in numerous animal models. In the present study, the tail suspension test (TST) and forced swim test (FST) were used to examine the roles of MOP and DOP in behavioral despair. MOP-KO mice and WT mice were treated with KNT-127 (10 mg/kg), a selective DOP agonist. The results indicated a significant decrease in immobility time in the KNT-127 group compared with the saline group in all genotypes in both tests. In the saline groups, immobility time significantly decreased in MOP-KO mice compared with WT mice in both tests. In female MOP-KO mice, KNT-127 significantly decreased immobility time in the TST compared with WT mice. In male MOP-KO mice, however, no genotypic differences were found in the TST after either KNT-127 or saline treatment. Thus, at least in the FST and TST, the activation of DOP and absence of MOP had additive effects in reducing measures of behavioral despair, suggesting that effects on this behavior by DOP activation occur independently of MOP.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Opioides mu / Morfinanos Límite: Animals Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Opioides mu / Morfinanos Límite: Animals Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón